Bionomics Ltd Adr Stock Current Valuation
Valuation analysis of Bionomics ADR helps investors to measure Bionomics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Bionomics Ltd ADR Company Current Valuation Analysis
Bionomics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bionomics Current Valuation | 14.16 B |
Most of Bionomics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bionomics Ltd ADR has a Current Valuation of 14.16 B. This indicator is about the same for the Biotechnology average (which is currently at 14.36 B) sector and 204.76% higher than that of the Health Care industry. The current valuation for all United States stocks is 14.84% higher than that of the company.
Bionomics Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in current valuation category among its peers.
Bionomics Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | 89.10 % | |||
| Current Valuation | 14.16 B | |||
| Shares Outstanding | 1.63 M | |||
| Shares Owned By Insiders | 33.91 % | |||
| Shares Owned By Institutions | 16.22 % | |||
| Number Of Shares Shorted | 400.4 K | |||
| Price To Book | 829.81 X | |||
| Price To Sales | 386.72 X | |||
| Revenue | 20 K | |||
| Gross Profit | (18.96 M) | |||
| EBITDA | (9.84 M) | |||
| Net Income | (15.49 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 4.46 X | |||
| Total Debt | 272.74 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 12.46 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (14.68 M) | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (14.32) X | |||
| Target Price | 9.58 | |||
| Beta | -0.069 | |||
| Market Capitalization | 4.95 M | |||
| Total Asset | 27.65 M | |||
| Retained Earnings | (177.98 M) | |||
| Working Capital | 9.36 M | |||
| Net Asset | 27.65 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |